No preclinical rationale for IGF1R directed therapy in chondrosarcoma of bone

BACKGROUND: Chondrosarcoma is a malignant cartilage forming bone tumour for which no effective systemic treatment is available. Previous studies illustrate the need for a better understanding of the role of the IGF pathway in chondrosarcoma to determine if it can be a target for therapy, which was t...

Descripción completa

Detalles Bibliográficos
Autores principales: Peterse, Elisabeth F. P., Cleven, Arjen H. G., De Jong, Yvonne, Briaire-de Bruijn, Inge, Fletcher, Jonathan A., Danen, Erik H. J., Cleton-Jansen, Anne-Marie, Bovée, Judith V. M. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946092/
https://www.ncbi.nlm.nih.gov/pubmed/27418340
http://dx.doi.org/10.1186/s12885-016-2522-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946092/
https://www.ncbi.nlm.nih.gov/pubmed/27418340
http://dx.doi.org/10.1186/s12885-016-2522-8

Ejemplares similares